Hereditary leiomyomatosis and renal cell cancer syndrome: identification and clinical characterization of a novel mutation in the FH gene in a Colombian family
- 26 August 2016
- journal article
- case report
- Published by Springer Nature in Familial Cancer
- Vol. 16 (1) , 117-122
Abstract
Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome (HLRCC) is a rare disease and since the first report, it has been found in just over 200 families approximately, around the world (Smit et al. in Clin Genet 79:49–59, 2009 ). Patients in Colombia or in Latin America have not been described, as far as we know. HLRCC is inherited in an autosomal dominant manner, and it is caused by heterozygous germline mutations in the FH gene, which encodes the fumarate hydratase enzyme. It is characterized mainly by the appearance of cutaneous and uterine leiomyomas, and an early-onset, aggressive form of type 2- papillary renal cell carcinoma (Smit et al. in Clin Genet 79:49–59, 2009 ; Schmidt and Linehan in Int J Nephrol Renovasc Dis 7:253–260, 2014 ]. We report a Colombian family with HLRCC syndrome, with a novel mutation in FH gene (c.1349_1352delATGA) in which cutaneous leiomyomas have not been found, but other clinical manifestations such as type 2- papillary renal cell carcinoma, uterine leiomyomas and rare tumors were present. This investigation constitutes the first report of HLRCC syndrome in Colombia, and probably in Latin America.Keywords
This publication has 20 references indexed in Scilit:
- Molecular Pathways: Fumarate Hydratase-Deficient Kidney Cancer—Targeting the Warburg Effect in CancerClinical Cancer Research, 2013
- Ethical and Policy Issues in Genetic Testing and Screening of ChildrenPediatrics, 2013
- Renal Cyst Formation in Fh1-Deficient Mice Is Independent of the Hif/Phd Pathway: Roles for Fumarate in KEAP1 Succination and Nrf2 SignalingCancer Cell, 2011
- Aberrant succination of proteins in fumarate hydratase‐deficient mice and HLRCC patients is a robust biomarker of mutation statusThe Journal of Pathology, 2011
- Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysisClinical Genetics, 2010
- Increased risk of cancer in patients with fumarate hydratase germline mutationJournal of Medical Genetics, 2006
- Clinical Features of Multiple Cutaneous and Uterine LeiomyomatosisArchives of Dermatology, 2005
- Mutations in the Fumarate Hydratase Gene Cause Hereditary Leiomyomatosis and Renal Cell Cancer in Families in North AmericaThe American Journal of Human Genetics, 2003
- Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiencyHuman Molecular Genetics, 2003
- Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancerNature Genetics, 2002